ID: ALA5273354

Max Phase: Preclinical

Molecular Formula: C10H12N4O3S2

Molecular Weight: 300.37

Associated Items:

Representations

Canonical SMILES:  COCCCNc1nnc(-c2ccc([N+](=O)[O-])s2)s1

Standard InChI:  InChI=1S/C10H12N4O3S2/c1-17-6-2-5-11-10-13-12-9(19-10)7-3-4-8(18-7)14(15)16/h3-4H,2,5-6H2,1H3,(H,11,13)

Standard InChI Key:  UXYUOFGJQDEMHE-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania major 2877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.37Molecular Weight (Monoisotopic): 300.0351AlogP: 2.62#Rotatable Bonds: 7
Polar Surface Area: 90.18Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.78CX Basic pKa: 0.06CX LogP: 1.83CX LogD: 1.83
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.48Np Likeness Score: -2.28

References

1. Kapil S, Singh PK, Silakari O..  (2018)  An update on small molecule strategies targeting leishmaniasis.,  157  [PMID:30099256] [10.1016/j.ejmech.2018.08.012]

Source